| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcal Infections | 17 | 2021 | 176 | 3.210 |
Why?
|
| Cross Infection | 22 | 2023 | 304 | 2.690 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 12 | 2023 | 124 | 2.130 |
Why?
|
| Bacteremia | 14 | 2017 | 117 | 2.070 |
Why?
|
| Community-Acquired Infections | 13 | 2021 | 78 | 1.790 |
Why?
|
| Staphylococcus aureus | 8 | 2021 | 85 | 1.620 |
Why?
|
| Methicillin Resistance | 7 | 2012 | 31 | 1.610 |
Why?
|
| Hospitals | 6 | 2022 | 157 | 1.580 |
Why?
|
| Catheter-Related Infections | 9 | 2023 | 28 | 1.550 |
Why?
|
| Anti-Bacterial Agents | 11 | 2021 | 401 | 1.320 |
Why?
|
| Patient Safety | 2 | 2022 | 50 | 1.290 |
Why?
|
| Infection Control | 10 | 2015 | 174 | 1.230 |
Why?
|
| Intensive Care Units | 10 | 2020 | 312 | 1.160 |
Why?
|
| Staphylococcal Skin Infections | 4 | 2011 | 14 | 1.060 |
Why?
|
| Health Information Exchange | 2 | 2022 | 5 | 0.980 |
Why?
|
| Population Surveillance | 7 | 2010 | 118 | 0.940 |
Why?
|
| Quality Indicators, Health Care | 3 | 2022 | 39 | 0.880 |
Why?
|
| Hospitalization | 4 | 2022 | 319 | 0.830 |
Why?
|
| Catheterization, Central Venous | 7 | 2015 | 42 | 0.830 |
Why?
|
| United States | 19 | 2022 | 2344 | 0.800 |
Why?
|
| Pandemics | 2 | 2022 | 237 | 0.800 |
Why?
|
| Humans | 67 | 2023 | 29814 | 0.790 |
Why?
|
| Soft Tissue Infections | 4 | 2011 | 28 | 0.770 |
Why?
|
| Medicare | 1 | 2022 | 123 | 0.770 |
Why?
|
| Electronic Health Records | 4 | 2015 | 66 | 0.680 |
Why?
|
| Benchmarking | 2 | 2019 | 42 | 0.680 |
Why?
|
| Betacoronavirus | 1 | 2020 | 75 | 0.660 |
Why?
|
| Quality of Health Care | 2 | 2019 | 138 | 0.660 |
Why?
|
| Critical Illness | 1 | 2020 | 127 | 0.650 |
Why?
|
| HIV Infections | 6 | 2013 | 997 | 0.650 |
Why?
|
| Chicago | 15 | 2020 | 867 | 0.640 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 86 | 0.630 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 89 | 0.630 |
Why?
|
| Risk Assessment | 2 | 2020 | 683 | 0.610 |
Why?
|
| Risk Factors | 13 | 2021 | 2465 | 0.560 |
Why?
|
| Sepsis | 2 | 2010 | 147 | 0.540 |
Why?
|
| Fluoroquinolones | 2 | 2006 | 25 | 0.520 |
Why?
|
| Disease Outbreaks | 3 | 2011 | 89 | 0.520 |
Why?
|
| Male | 33 | 2023 | 15851 | 0.480 |
Why?
|
| Female | 34 | 2023 | 16412 | 0.480 |
Why?
|
| Adult | 27 | 2023 | 8741 | 0.470 |
Why?
|
| Middle Aged | 26 | 2022 | 9960 | 0.470 |
Why?
|
| Nose | 2 | 2013 | 35 | 0.420 |
Why?
|
| Algorithms | 4 | 2014 | 400 | 0.410 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2009 | 52 | 0.400 |
Why?
|
| Prisons | 2 | 2013 | 12 | 0.400 |
Why?
|
| Retrospective Studies | 15 | 2020 | 3325 | 0.390 |
Why?
|
| Creatine Kinase | 4 | 2015 | 33 | 0.390 |
Why?
|
| HIV | 1 | 2012 | 92 | 0.390 |
Why?
|
| Phenotype | 5 | 2021 | 362 | 0.380 |
Why?
|
| Myositis | 4 | 2015 | 40 | 0.380 |
Why?
|
| Bacteriuria | 1 | 2010 | 5 | 0.370 |
Why?
|
| Knowledge Bases | 1 | 2010 | 3 | 0.350 |
Why?
|
| Chlorhexidine | 4 | 2012 | 61 | 0.350 |
Why?
|
| Aged | 17 | 2022 | 9620 | 0.340 |
Why?
|
| Public Health | 2 | 2022 | 62 | 0.330 |
Why?
|
| Neutropenia | 1 | 2008 | 21 | 0.320 |
Why?
|
| Cohort Studies | 8 | 2022 | 1952 | 0.310 |
Why?
|
| Incidence | 7 | 2014 | 759 | 0.300 |
Why?
|
| Public Housing | 1 | 2007 | 4 | 0.290 |
Why?
|
| Anti-Infective Agents, Local | 4 | 2012 | 52 | 0.290 |
Why?
|
| Confidentiality | 3 | 2015 | 11 | 0.280 |
Why?
|
| Databases, Factual | 4 | 2015 | 331 | 0.280 |
Why?
|
| Baths | 3 | 2012 | 27 | 0.270 |
Why?
|
| Case-Control Studies | 4 | 2022 | 641 | 0.270 |
Why?
|
| Academic Medical Centers | 5 | 2015 | 142 | 0.270 |
Why?
|
| Genomics | 3 | 2021 | 43 | 0.260 |
Why?
|
| Developing Countries | 1 | 2005 | 21 | 0.260 |
Why?
|
| Gram-Negative Aerobic Bacteria | 1 | 2005 | 4 | 0.260 |
Why?
|
| Aspartate Aminotransferases | 2 | 2015 | 19 | 0.250 |
Why?
|
| Alanine Transaminase | 2 | 2015 | 23 | 0.250 |
Why?
|
| Fomites | 1 | 2004 | 4 | 0.240 |
Why?
|
| Carrier State | 3 | 2013 | 52 | 0.240 |
Why?
|
| Disinfection | 1 | 2004 | 11 | 0.240 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 4 | 2015 | 39 | 0.240 |
Why?
|
| Adolescent | 7 | 2022 | 2332 | 0.230 |
Why?
|
| Skin | 3 | 2014 | 118 | 0.230 |
Why?
|
| Patient-Centered Care | 2 | 2015 | 61 | 0.230 |
Why?
|
| Regression Analysis | 2 | 2015 | 298 | 0.220 |
Why?
|
| Text Messaging | 1 | 2023 | 14 | 0.220 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2023 | 17 | 0.220 |
Why?
|
| Urinary Tract Infections | 1 | 2023 | 32 | 0.210 |
Why?
|
| Prognosis | 4 | 2022 | 874 | 0.210 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2021 | 110 | 0.210 |
Why?
|
| Illinois | 4 | 2021 | 241 | 0.210 |
Why?
|
| Hospitals, Public | 4 | 2015 | 31 | 0.200 |
Why?
|
| Skin Care | 2 | 2012 | 14 | 0.190 |
Why?
|
| Clostridium Infections | 2 | 2012 | 19 | 0.190 |
Why?
|
| Medical Record Linkage | 3 | 2015 | 5 | 0.190 |
Why?
|
| Disease Transmission, Infectious | 1 | 2021 | 21 | 0.190 |
Why?
|
| Comorbidity | 2 | 2020 | 504 | 0.190 |
Why?
|
| Occupational Exposure | 1 | 2021 | 25 | 0.190 |
Why?
|
| Palliative Care | 1 | 2022 | 149 | 0.180 |
Why?
|
| Young Adult | 7 | 2022 | 1966 | 0.180 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2010 | 16 | 0.180 |
Why?
|
| Sexual and Gender Minorities | 1 | 2020 | 25 | 0.170 |
Why?
|
| Multivariate Analysis | 3 | 2013 | 332 | 0.170 |
Why?
|
| Health Personnel | 1 | 2021 | 115 | 0.170 |
Why?
|
| Time Factors | 6 | 2022 | 1641 | 0.170 |
Why?
|
| Aged, 80 and over | 7 | 2022 | 4930 | 0.170 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2010 | 10 | 0.170 |
Why?
|
| Sentinel Surveillance | 2 | 2009 | 8 | 0.170 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2018 | 11 | 0.160 |
Why?
|
| Prevalence | 3 | 2020 | 494 | 0.150 |
Why?
|
| Purines | 1 | 2018 | 34 | 0.150 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2009 | 12 | 0.150 |
Why?
|
| Myocardial Ischemia | 1 | 2018 | 49 | 0.150 |
Why?
|
| Pyrazoles | 1 | 2018 | 50 | 0.150 |
Why?
|
| Medical Audit | 1 | 2017 | 7 | 0.150 |
Why?
|
| Antimicrobial Stewardship | 1 | 2017 | 10 | 0.150 |
Why?
|
| Electrocardiography | 1 | 2018 | 219 | 0.150 |
Why?
|
| Inappropriate Prescribing | 1 | 2017 | 6 | 0.150 |
Why?
|
| Hygiene | 2 | 2008 | 13 | 0.150 |
Why?
|
| Medical Staff, Hospital | 1 | 2017 | 19 | 0.150 |
Why?
|
| Internal Medicine | 1 | 2017 | 32 | 0.140 |
Why?
|
| Dermatomyositis | 2 | 2014 | 16 | 0.140 |
Why?
|
| Bacterial Infections | 2 | 2009 | 66 | 0.140 |
Why?
|
| Prospective Studies | 3 | 2023 | 1823 | 0.140 |
Why?
|
| Heart Valves | 1 | 2016 | 5 | 0.140 |
Why?
|
| Endocarditis | 1 | 2016 | 9 | 0.140 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2016 | 22 | 0.130 |
Why?
|
| Time-to-Treatment | 1 | 2016 | 33 | 0.130 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 43 | 0.130 |
Why?
|
| Hospital Units | 1 | 2015 | 9 | 0.130 |
Why?
|
| Bacterial Load | 2 | 2013 | 13 | 0.130 |
Why?
|
| Multicenter Studies as Topic | 1 | 2015 | 77 | 0.130 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 20 | 0.130 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 532 | 0.130 |
Why?
|
| Civil Defense | 1 | 2015 | 7 | 0.130 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 7 | 0.130 |
Why?
|
| Gram-Positive Bacteria | 2 | 2012 | 16 | 0.130 |
Why?
|
| Prednisone | 1 | 2015 | 68 | 0.130 |
Why?
|
| Software | 1 | 2015 | 72 | 0.120 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2012 | 41 | 0.120 |
Why?
|
| Hospital Information Systems | 1 | 2014 | 5 | 0.120 |
Why?
|
| HIV-1 | 2 | 2009 | 451 | 0.120 |
Why?
|
| Bacterial Proteins | 2 | 2014 | 76 | 0.120 |
Why?
|
| Health Services Research | 1 | 2015 | 42 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 102 | 0.120 |
Why?
|
| Registries | 2 | 2022 | 191 | 0.120 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 135 | 0.120 |
Why?
|
| Computer Communication Networks | 1 | 2014 | 4 | 0.120 |
Why?
|
| Pharynx | 1 | 2014 | 14 | 0.120 |
Why?
|
| Nasal Cavity | 1 | 2014 | 35 | 0.120 |
Why?
|
| Information Dissemination | 1 | 2014 | 22 | 0.120 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 2014 | 4 | 0.120 |
Why?
|
| Sensitivity and Specificity | 3 | 2011 | 558 | 0.120 |
Why?
|
| International Classification of Diseases | 2 | 2011 | 23 | 0.110 |
Why?
|
| Hospitals, Urban | 2 | 2015 | 35 | 0.110 |
Why?
|
| Genotype | 2 | 2012 | 399 | 0.110 |
Why?
|
| Models, Statistical | 2 | 2012 | 132 | 0.110 |
Why?
|
| Molecular Epidemiology | 3 | 2021 | 26 | 0.110 |
Why?
|
| Stroke | 1 | 2016 | 294 | 0.100 |
Why?
|
| Reproducibility of Results | 5 | 2014 | 802 | 0.100 |
Why?
|
| Colectomy | 1 | 2012 | 20 | 0.100 |
Why?
|
| Gram-Negative Bacteria | 2 | 2009 | 37 | 0.100 |
Why?
|
| Treatment Outcome | 5 | 2016 | 3561 | 0.100 |
Why?
|
| Virulence | 1 | 2011 | 15 | 0.100 |
Why?
|
| RNA, Viral | 2 | 2009 | 159 | 0.100 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2011 | 9 | 0.100 |
Why?
|
| Length of Stay | 2 | 2010 | 320 | 0.100 |
Why?
|
| Klebsiella Infections | 1 | 2011 | 56 | 0.100 |
Why?
|
| Clinical Coding | 1 | 2011 | 6 | 0.090 |
Why?
|
| Klebsiella pneumoniae | 1 | 2011 | 61 | 0.090 |
Why?
|
| beta-Lactamases | 1 | 2011 | 72 | 0.090 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 156 | 0.090 |
Why?
|
| Models, Economic | 1 | 2010 | 9 | 0.090 |
Why?
|
| Computer Security | 3 | 2015 | 8 | 0.090 |
Why?
|
| Pulmonary Embolism | 1 | 2011 | 59 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 48 | 0.090 |
Why?
|
| Geography | 1 | 2010 | 22 | 0.090 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2010 | 44 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2010 | 53 | 0.090 |
Why?
|
| Automation | 1 | 2010 | 11 | 0.090 |
Why?
|
| Hospital Costs | 1 | 2010 | 68 | 0.090 |
Why?
|
| Drug Utilization | 1 | 2009 | 27 | 0.090 |
Why?
|
| Branched DNA Signal Amplification Assay | 1 | 2009 | 1 | 0.090 |
Why?
|
| Arthritis, Infectious | 1 | 2010 | 58 | 0.080 |
Why?
|
| Viremia | 1 | 2009 | 37 | 0.080 |
Why?
|
| Drug Utilization Review | 1 | 2009 | 7 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 156 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2009 | 70 | 0.080 |
Why?
|
| Disease Notification | 1 | 2008 | 4 | 0.080 |
Why?
|
| Pattern Recognition, Automated | 1 | 2008 | 9 | 0.080 |
Why?
|
| Data Collection | 1 | 2009 | 108 | 0.080 |
Why?
|
| Feces | 2 | 2008 | 97 | 0.080 |
Why?
|
| Viral Load | 1 | 2009 | 208 | 0.080 |
Why?
|
| Phylogeny | 2 | 2021 | 63 | 0.080 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2008 | 20 | 0.080 |
Why?
|
| Gram-Positive Cocci | 1 | 2008 | 5 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2008 | 22 | 0.080 |
Why?
|
| Foodborne Diseases | 1 | 2008 | 3 | 0.080 |
Why?
|
| Drug Administration Routes | 1 | 2008 | 12 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2009 | 135 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2008 | 94 | 0.080 |
Why?
|
| Drainage | 1 | 2008 | 50 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 232 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2008 | 310 | 0.080 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2007 | 25 | 0.070 |
Why?
|
| Drug Resistance, Viral | 1 | 2007 | 40 | 0.070 |
Why?
|
| Critical Care | 1 | 2010 | 242 | 0.070 |
Why?
|
| Genome, Bacterial | 2 | 2017 | 14 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 73 | 0.070 |
Why?
|
| Anti-HIV Agents | 1 | 2007 | 173 | 0.070 |
Why?
|
| DNA, Bacterial | 2 | 2017 | 49 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 194 | 0.070 |
Why?
|
| Hip Joint | 1 | 2010 | 357 | 0.070 |
Why?
|
| Heart-Assist Devices | 1 | 2005 | 22 | 0.060 |
Why?
|
| Virus Diseases | 1 | 2004 | 16 | 0.060 |
Why?
|
| Mycoses | 1 | 2004 | 22 | 0.060 |
Why?
|
| Polymyositis | 2 | 2014 | 10 | 0.060 |
Why?
|
| Mass Screening | 1 | 2005 | 180 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1126 | 0.060 |
Why?
|
| Poisson Distribution | 2 | 2015 | 25 | 0.050 |
Why?
|
| Therapies, Investigational | 1 | 2022 | 7 | 0.050 |
Why?
|
| Prosthesis-Related Infections | 1 | 2005 | 215 | 0.050 |
Why?
|
| Social Determinants of Health | 1 | 2022 | 28 | 0.050 |
Why?
|
| Methicillin | 1 | 2021 | 6 | 0.050 |
Why?
|
| Molecular Typing | 1 | 2021 | 7 | 0.050 |
Why?
|
| Drug Therapy, Combination | 2 | 2015 | 245 | 0.050 |
Why?
|
| Maryland | 1 | 2021 | 8 | 0.050 |
Why?
|
| Georgia | 1 | 2021 | 12 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 20 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 334 | 0.050 |
Why?
|
| Biomarkers | 2 | 2014 | 704 | 0.050 |
Why?
|
| Homosexuality, Male | 1 | 2020 | 24 | 0.050 |
Why?
|
| Disease Progression | 1 | 2022 | 812 | 0.040 |
Why?
|
| Linear Models | 2 | 2010 | 258 | 0.040 |
Why?
|
| Hospitals, Teaching | 2 | 2009 | 33 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2021 | 216 | 0.040 |
Why?
|
| Patient Discharge | 2 | 2010 | 151 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2022 | 384 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 970 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 1462 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 75 | 0.040 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2017 | 6 | 0.040 |
Why?
|
| Exercise Test | 1 | 2018 | 124 | 0.040 |
Why?
|
| Feedback | 1 | 2017 | 32 | 0.040 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2018 | 57 | 0.040 |
Why?
|
| Glasgow Outcome Scale | 1 | 2016 | 2 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 24 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2016 | 30 | 0.030 |
Why?
|
| Cerebral Angiography | 1 | 2016 | 30 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2016 | 154 | 0.030 |
Why?
|
| Urban Health Services | 1 | 2015 | 13 | 0.030 |
Why?
|
| Safety-net Providers | 1 | 2015 | 8 | 0.030 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2015 | 2 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 5 | 0.030 |
Why?
|
| Management Audit | 1 | 2014 | 2 | 0.030 |
Why?
|
| Interinstitutional Relations | 1 | 2015 | 10 | 0.030 |
Why?
|
| Epidemiological Monitoring | 1 | 2014 | 7 | 0.030 |
Why?
|
| Patient Selection | 1 | 2016 | 234 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2015 | 110 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2015 | 129 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2014 | 45 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 456 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2015 | 104 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 329 | 0.030 |
Why?
|
| Information Systems | 1 | 2014 | 21 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 51 | 0.030 |
Why?
|
| Liver Diseases | 1 | 2014 | 40 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2014 | 158 | 0.030 |
Why?
|
| Contact Tracing | 1 | 2011 | 6 | 0.020 |
Why?
|
| Multilocus Sequence Typing | 1 | 2011 | 10 | 0.020 |
Why?
|
| Indiana | 1 | 2011 | 17 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 2011 | 12 | 0.020 |
Why?
|
| Utah | 1 | 2011 | 2 | 0.020 |
Why?
|
| Baltimore | 1 | 2011 | 14 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2011 | 44 | 0.020 |
Why?
|
| Drug Costs | 1 | 2010 | 17 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2010 | 36 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2010 | 48 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2010 | 120 | 0.020 |
Why?
|
| Soaps | 1 | 2010 | 9 | 0.020 |
Why?
|
| Biological Assay | 1 | 2010 | 9 | 0.020 |
Why?
|
| Hospitals, Special | 1 | 2009 | 6 | 0.020 |
Why?
|
| APACHE | 1 | 2009 | 28 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2009 | 15 | 0.020 |
Why?
|
| Culture Media | 1 | 2009 | 36 | 0.020 |
Why?
|
| Blood | 1 | 2009 | 25 | 0.020 |
Why?
|
| Long-Term Care | 1 | 2009 | 56 | 0.020 |
Why?
|
| Acute Disease | 1 | 2010 | 225 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2009 | 37 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2009 | 40 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 398 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2011 | 508 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2009 | 67 | 0.020 |
Why?
|
| Escherichia coli O157 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Salmonella | 1 | 2008 | 5 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2008 | 67 | 0.020 |
Why?
|
| Diarrhea | 1 | 2008 | 47 | 0.020 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2007 | 9 | 0.020 |
Why?
|
| HIV Protease | 1 | 2007 | 9 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2008 | 218 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2007 | 157 | 0.020 |
Why?
|
| Inpatients | 1 | 2009 | 141 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2007 | 161 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2008 | 129 | 0.020 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2005 | 4 | 0.020 |
Why?
|
| Mutation | 1 | 2007 | 396 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2005 | 37 | 0.020 |
Why?
|